After chronic and subacute oral administration of deoxynivalenol (DON), mice liver manifested inflammatory damage, focal steatosis, focal fibrosis and activated caspase-3 as well as GSDME, which were suppressed by the caspase-3 inhibitor Z-DEVD and Ac-DEVD [75]. The gene discussed is CASP3; the disease is steatosis.